TSHA - Taysha Gene Therapies  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TSHA is currently covered by 12 analysts with an average price target of $11.37. This is a potential upside of $8.29 (269.16%) from yesterday's end of day stock price of $3.08.

Taysha Gene Therapies 's activity chart (see below) currently has 35 price targets and 95 ratings on display. The stock rating distribution of TSHA is 94.64% BUY and 5.36% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.11% with an average time for these price targets to be met of 84.07 days.

Highest price target for TSHA is $8, Lowest price target is $5, average price target is $11.37.

Most recent stock forecast was given by WHITNEY IJEM from CANACCORD on 15-Nov-2024. First documented stock forecast 19-Oct-2020.

Currently out of the existing stock ratings of TSHA, 53 are a BUY (94.64%), 3 are a HOLD (5.36%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

$4.76 (146.91%)

$6

17 days ago
(15-Nov-2024)

0/4 (0%)

$5.99 (298.01%)

Buy

$6

$2.76 (85.19%)

$6

18 days ago
(14-Nov-2024)

0/15 (0%)

$3.55 (144.90%)

Buy

$7

$3.76 (116.05%)

$7

18 days ago
(14-Nov-2024)

1/12 (8.33%)

$4.55 (185.71%)

137

Buy

$5

$1.76 (54.32%)

$5

20 days ago
(12-Nov-2024)

2/8 (25%)

$2.87 (134.74%)

401

Buy

$7

$3.76 (116.05%)

$7

5 months 13 days ago
(19-Jun-2024)

0/6 (0%)

$4.03 (135.69%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TSHA (Taysha Gene Therapies ) average time for price targets to be met?

On average it took 84.07 days on average for the stock forecasts to be realized with a an average price target met ratio 16.11

Which analyst has the current highest performing score on TSHA (Taysha Gene Therapies ) with a proven track record?

SALVEEN RICHTER

Which analyst has the most public recommendations on TSHA (Taysha Gene Therapies )?

Salveen Richter works at GOLDMAN SACHS and has 8 price targets and 5 ratings on TSHA

Which analyst is the currently most bullish on TSHA (Taysha Gene Therapies )?

Yanan Zhu with highest potential upside - $6.76

Which analyst is the currently most reserved on TSHA (Taysha Gene Therapies )?

Salveen Richter with lowest potential downside - -$0.24

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?